cloudfront

Report Detail



OtherGlobal Endometriosis Therapies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2541486
  • |
  • 5 November, 2018
  • |
  • Global
  • |
  • 119 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Global Endometriosis Therapies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Endometriosis Therapies Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Hormonal Contraceptives
  • 1.2.2 Gonadotropin-releasing Hormone (Gn-RH) Agonists
  • 1.2.3 Progestin Therapy
  • 1.2.4 Aromatase Inhibitors
  • 1.3 Market Analysis by Applications
  • 1.3.1 Hospital
  • 1.3.2 Clinic
  • 1.3.3 Other
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 AbbVie
    • 2.1.1 Business Overview
  • 2.1.2 Endometriosis Therapies Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 AbbVie Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Eli Lilly
  • 2.2.1 Business Overview
  • 2.2.2 Endometriosis Therapies Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Eli Lilly Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 AstraZeneca
  • 2.3.1 Business Overview
  • 2.3.2 Endometriosis Therapies Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 AstraZeneca Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Bayer
  • 2.4.1 Business Overview
  • 2.4.2 Endometriosis Therapies Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Bayer Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Astellas Pharma
  • 2.5.1 Business Overview
  • 2.5.2 Endometriosis Therapies Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Astellas Pharma Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 Meditrina Pharmaceuticals
  • 2.6.1 Business Overview
  • 2.6.2 Endometriosis Therapies Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Pfizer
  • 2.7.1 Business Overview
  • 2.7.2 Endometriosis Therapies Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Pfizer Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 Neurocrine Biosciences
  • 2.8.1 Business Overview
  • 2.8.2 Endometriosis Therapies Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 Neurocrine Biosciences Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 Takeda Pharmaceutical
  • 2.9.1 Business Overview
  • 2.9.2 Endometriosis Therapies Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 Takeda Pharmaceutical Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Endometriosis Therapies Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Endometriosis Therapies Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Endometriosis Therapies Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Endometriosis Therapies Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Endometriosis Therapies Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Endometriosis Therapies Market Analysis by Regions

    • 4.1 Global Endometriosis Therapies Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Endometriosis Therapies Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Endometriosis Therapies Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 4.3 Europe Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 4.5 South America Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 5 North America Endometriosis Therapies by Countries

    • 5.1 North America Endometriosis Therapies Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Endometriosis Therapies Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Endometriosis Therapies Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 5.3 Canada Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 6 Europe Endometriosis Therapies by Countries

    • 6.1 Europe Endometriosis Therapies Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Endometriosis Therapies Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Endometriosis Therapies Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 6.3 UK Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 6.4 France Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 6.5 Russia Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 6.6 Italy Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Endometriosis Therapies by Countries

    • 7.1 Asia-Pacific Endometriosis Therapies Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Endometriosis Therapies Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Endometriosis Therapies Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 7.3 Japan Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 7.4 Korea Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 7.5 India Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 8 South America Endometriosis Therapies by Countries

    • 8.1 South America Endometriosis Therapies Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Endometriosis Therapies Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Endometriosis Therapies Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Endometriosis Therapies by Countries

    • 9.1 Middle East and Africa Endometriosis Therapies Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Endometriosis Therapies Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Endometriosis Therapies Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 9.3 UAE Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Endometriosis Therapies Sales and Growth Rate (2013-2018)
  • 10 Global Endometriosis Therapies Market Segment by Type

    • 10.1 Global Endometriosis Therapies Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Endometriosis Therapies Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Endometriosis Therapies Revenue and Market Share by Type (2013-2018)
  • 10.2 Hormonal Contraceptives Sales Growth and Price
  • 10.2.1 Global Hormonal Contraceptives Sales Growth (2013-2018)
  • 10.2.2 Global Hormonal Contraceptives Price (2013-2018)
  • 10.3 Gonadotropin-releasing Hormone (Gn-RH) Agonists Sales Growth and Price
  • 10.3.1 Global Gonadotropin-releasing Hormone (Gn-RH) Agonists Sales Growth (2013-2018)
  • 10.3.2 Global Gonadotropin-releasing Hormone (Gn-RH) Agonists Price (2013-2018)
  • 10.4 Progestin Therapy Sales Growth and Price
  • 10.4.1 Global Progestin Therapy Sales Growth (2013-2018)
  • 10.4.2 Global Progestin Therapy Price (2013-2018)
  • 10.5 Aromatase Inhibitors Sales Growth and Price
  • 10.5.1 Global Aromatase Inhibitors Sales Growth (2013-2018)
  • 10.5.2 Global Aromatase Inhibitors Price (2013-2018)
  • 11 Global Endometriosis Therapies Market Segment by Application

    • 11.1 Global Endometriosis Therapies Sales Market Share by Application (2013-2018)
    • 11.2 Hospital Sales Growth (2013-2018)
    • 11.3 Clinic Sales Growth (2013-2018)
    • 11.4 Other Sales Growth (2013-2018)

    12 Endometriosis Therapies Market Forecast (2018-2023)

    • 12.1 Global Endometriosis Therapies Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Endometriosis Therapies Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Endometriosis Therapies Market Forecast (2018-2023)
  • 12.2.2 Europe Endometriosis Therapies Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Endometriosis Therapies Market Forecast (2018-2023)
  • 12.2.4 South America Endometriosis Therapies Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Endometriosis Therapies Market Forecast (2018-2023)
  • 12.3 Endometriosis Therapies Market Forecast by Type (2018-2023)
  • 12.3.1 Global Endometriosis Therapies Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Endometriosis Therapies Market Share Forecast by Type (2018-2023)
  • 12.4 Endometriosis Therapies Market Forecast by Application (2018-2023)
  • 12.4.1 Global Endometriosis Therapies Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Endometriosis Therapies Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month

      Scope of the Report:

      The worldwide market for Endometriosis Therapies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      This report focuses on the Endometriosis Therapies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers

      AbbVie

      Eli Lilly

      AstraZeneca

      Bayer

      Astellas Pharma

      Meditrina Pharmaceuticals

      Pfizer

      Neurocrine Biosciences

      Takeda Pharmaceutical

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Hormonal Contraceptives

      Gonadotropin-releasing Hormone (Gn-RH) Agonists 

      Progestin Therapy

      Aromatase Inhibitors

      Market Segment by Applications, can be divided into

      Hospital

      Clinic

      Other

      There are 15 Chapters to deeply display the global Endometriosis Therapies market.

      Chapter 1, to describe Endometriosis Therapies Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Endometriosis Therapies, with sales, revenue, and price of Endometriosis Therapies, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Endometriosis Therapies, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Endometriosis Therapies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Endometriosis Therapies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on Endometriosis Therapies . Industry analysis & Market Report on Endometriosis Therapies is a syndicated market report, published as Global Endometriosis Therapies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Endometriosis Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Add To Cart Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report